|
| | 
|
 | |
         
|  |
|  |
|
Mostrar Noticias: Ver noticias de otros activosBúsqueda de noticias relacionadas a la acción Baxter Internatio (ordenadas por fecha):
|
Baxter Still Defensive, But Is Now The Time For Offense?Seeking AlphaThe best thing about Baxter (BAX) is that so much of its business comes from oligopolistic markets with pretty steady demand and reimbursement. The worst thing about Baxter is that so much of its business comes from oligopolistic markets with pretty ... |
|
Baxter Declares Quarterly DividendMarketWatch (press release)DEERFIELD, Ill., May 07, 2012 (BUSINESS WIRE) -- The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.335 per Baxter common share. The dividend is payable on July 2, 2012 to shareholders of record as ...y más » |
|
BAX Makes Bullish Cross Above Critical Moving AverageForbesIn trading on Thursday, shares of Baxter International Inc. (NYSE: BAX) crossed above their 200 day moving average of $54.62, changing hands as high as $54.97 per share. Baxter International Inc. shares are currently trading up about 0.4% on the day.y más » |
|
Baxter bitten again by problems with Colleague infusion pumpsFiercePharma ManufacturingBaxter ($BAX) is facing a new set of regulator entanglements related to the infusion pumps that were yanked from the market two years ago because manufacturing issues led to a host of problems. The company says it was served a subpoena in March by the ... |
|
Weighing The Benefits Of Osiris' First Cell Therapy ApprovalSeeking AlphaFor this simple reason, companies like Baxter (BAX) and Hospira (HSP) have relied on the manufacturing capabilities of other companies. NeoStem and its PCT business is the leader in the manufacturing of cell therapies. It has an unmatched 50000 square ...y más » |
|
Daily Dividend Report: D, BAX, L, IP, ALVForbesIn other dividend news, Baxter International Incorporated (BAX) maintained its quarterly dividend of 33.5 cents per share. Loews Corporation (L) maintained its quarterly dividend of 6.25 cents per share. International Paper Company (IP) maintained its ... |
|
Calendar spread is at work in BaxterNASDAQThe trade will perform best if BAX stays in its current range for the next five weeks. If the stock closes below $52.50 on June 15, the investor will lose the $2.22 initial outlay. Unlike most other market-neutral strategies, calendar spreads are ...y más » |
|
Becton Dickinson Remains NeutralZacks.comBecton, Dickinson faces a wide range of competitors, including Baxter International (BAX - Analyst Report) in certain niches, in each of its three business segments. We currently have a long-term Neutral recommendation on the stock.y más » |
|
3 Medical Device Stocks That Are Meaningfully UndervaluedSeeking AlphaIn this article, I will run you through my DCF model on Medtronic (MDT) and then triangulate the result against a review of the fundamentals compared to Baxter (BAX) and Abbott. I find all three meaningfully undervalued. For an industry as safe as ... |
|
Dr. Robin Smith Explaining NeoStem: A True Value PlaySeeking AlphaThe company also has clients such as Becton, Dickinson & Company (BDX), Baxter (BAX), and even Johnson & Johnson (JNJ). There are also a number of smaller companies using NeoStem's services as well as mid-sized companies such as Hospira (HSP).y más » |
|
China Biotech Week In Review: J&J Actively Pursuing M&A In ChinaSeeking AlphaBaxter International (NYSE: BAX) received approval from the SFDA of its treatment for hemophilia A, a product known as Advate (see story). Advate is a recombinant human coagulation factor VIII for injection used both for control and prevention of ... |
The Guardian |
Wapping great history: on the set of Outside BetThe GuardianOutside Bet tells the story of Bax, his ill father, Thimble, and a wise-cracking group of close friends across three generations from London. Down the pub, they receive an unusual offer ? a chance to buy a racehorse ? and rashly invest their ... |
|
5 Reasons To Buy NeoStem And 2 CatalystsSeeking AlphaBaxter (BAX) Phase III initiation provides further scientific and technical validation for NeoStem's technologies On February 28, 2012 Baxter International announced that it has initiated a Phase III pivotal clinical trial to evaluate the efficacy and ...y más » |
|
OUTSIDE BETExpress.co.ukCalum MacNab gives a likeable performance as Mark ?Bax? Baxter, a young dreamer who has followed his father Threads (Phil Davis) into the print trade where a job is meant to last you a lifetime. However this is the Britain of 1985, where the industry ...y más » |
|
A money manager's top 3 purchasesMSN MoneyAuxier's top three new purchases in the first quarter of 2012 were: Baxter International (BAX), Becton Dickinson (BDX) and Carnival Corp. (CCL). Auxier bought 22715 shares of Baxter International at an average price of $56. In the first quarter, ... |
Fortune |
Obama begins anti-Bain campaignFortuneBain originally created Dade International in 2004, by purchasing the medical diagnostics business of Baxter International (BAX) for $448 million. At the time, it was a failing unit. For example, MLA had just canceled a large blood analyzer/reagents ...y más » |
|
Kamada in Partnership Talks for Inhaled Medicine, CEO SaysBusinessWeekThe company already sells an intravenous version of the compound, which brought in US sales of 93 million shekels ($24.5 million) for Kamada last year, with Baxter International Inc. (BAX) (BAX) An inhaled version would have no rival and be easier to ...y más » |
|
A Halo Comes OffSeeking Alpha... deals with such established players as Roche (RHHBY), Baxter (BAX), ViroPharma (VPHM), and Intrexon to apply Enhanze technology to drugs that are already FDA approved, and which the partners are already generating substantial revenues from. |
|
2 Dividend Growth Companies With Potential To Boost PayoutsSeeking AlphaThe company's peers, namely Baxter (BAX), Medtronic (MDT) and St Jude Medical (STJ) are yielding 2.4%, 2.5%, and 2.4%, respectively, while Boston Scientific (BSX) is not paying any dividends. We also like Medtronic and Baxter in this group. |
|
NeoStem: Huge Potential In The Cell Therapy SectorSeeking AlphaJMP Securities reiterated its market outperform rating and $3 price target for NeoStem, after BAXTER International (BAX) named the stem cell company's Progenitor Cell Therapy unit [PCT] as the contract manufacturer for a Phase III stem cell trial with ... |
|
LISTINGS: Events, Exhibitions - May 17 - May 24Sheffield Telegraph... photography, poetry, artists' books and graphic design with contributions from artists Bryan Eccleshall, Wild Pansy Press, Angelina Ayers, Ian Baxter, Richard Steadman Jones, Glyn Thompson, Becky Fisher, Adam Piette and Nick Bax, Bank Street Arts, ... |
|
Indicated Dividend Yield Ranking for the S&P 500 by IndustryBusinessWeek... MJN Mead Johnson Nutrition Co 1.40 0.30 41.8 TSN Tyson Foods Inc 0.88 0.04 8.0 Health Care Equipment & Services 1.49 17.4 MDT Medtronic Inc 2.57 0.24 31.3 BAX Baxter International Inc 2.43 0.34 32.4 STJ St Jude Medical Inc 2.38 0.23 33.0 BDX Becton ...y más » |
Little White Lies |
Outside BetLittle White LiesThat lead character is Mark 'Bax' Baxter played by Calum MacNab, a young print worker with a cheeky glint in his eye who loafs with his chums in a generic Camberwell boozer. Those pals include ? and these are, we assure you, their actual character ... |
|
S&P 500 Annual Meeting Calendar, Week of April 30 - May 25BusinessWeek... 11 5/5 BRK/B Berkshire Hathaway Inc 5/7 AFL Aflac Inc 5/7 IP International Paper Co 5/8 NWL Newell Rubbermaid Inc 5/8 ZMH Zimmer Holdings Inc 5/8 CLF Cliffs Natural Resources Inc 5/8 CBG CBRE Group Inc 5/8 BAX Baxter International Inc 5/8 MAS Masco ... |
|
Forbes Earnings Preview: HospiraForbesOne of Hospira's main competitors in the healthcare equipment and supplies industry is Baxter International (BAX). Other competitors in the healthcare sector include: Teva Pharmaceutical (TEVA), Mylan (MYL), and Akorn (AKRX). The stock price has fallen ...y más » |
|
Who's missing from the CEO pay list? Short answer: EuropeansFiercePharma10, Robert Parkinson at Baxter International ($BAX). Sanofi ($SNY), which is expected to vault into first place among Big Pharma by 2014, delivered ?7.135 million ($9.45 million) to its CEO, Chris Viehbacher. Merck's ($MRK) Kenneth Frazier did somewhat ... |
|
Anchura de la Página:
Imagen de Fondo: |
|  | |
|
|
